Final results from a phase I trial of ixabepilone in patients with advanced malignancies and lymphoma.

被引：0
|
作者：
Aghajanian, C.
O'Connor, O.
Cohen, M.
Peck, R.
Burris, H.
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Bristol Myers Squibb Co, Princeton, NJ 08543 USA
[3] Bristol Myers Squibb Co, Wallingford, CT USA
[4] Sarah Cannon Res Inst, Nashville, TN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：88S / 88S
页数：1
相关论文
共 50 条
  • [21] Final results of a phase I trial of oral vorinostat (Suberoylanilide hydroxamic acid, SAHA) in patients with advanced multiple myeloma
    Richardson, Paul G.
    Mitsiades, Constantine S.
    Colson, Kathleen
    Reilly, Eileen
    McBride, Laura
    Chiao, Judy
    Sun, Linda
    Ricker, Justin L.
    Rizvi, Syed
    Oerth, Carol
    Atkins, Barbara
    Fearen, Ivy
    Anderson, Kenneth C.
    Siegel, David S.
    BLOOD, 2007, 110 (11) : 357A - 357A
  • [22] A phase I study of an oral formulation of ixabepilone (ixa) in patients with advanced cancer
    He, A. R.
    Kunz, P. L.
    Pishvaian, M. J.
    Colevas, A. D.
    Hwang, J. J.
    Clemens, P. L.
    Messina, M.
    Kaleta, R.
    Abrahao, F.
    Sikic, B. I.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [23] Final results of a phase I study of amrubicin and cyclophosphamide in patients with advanced solid organ malignancies: HOG LUN 07-130
    Jalal, Shadia Ibrahim
    Hanna, Nasser H.
    Zon, Robin
    Masters, Gregory A.
    Borghaei, Hossein
    Koneru, Karuna
    Badve, Sunil S.
    Prasad, Nagendra K.
    Somaiah, Neeta
    Wu, Jingwei
    Yu, Zhangsheng
    Einhorn, Lawrence H.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [24] A Phase I Trial to Determine the Safety of Imatinib in Combination With Vatalanib in Patients With Advanced Malignancies
    Spigel, David
    Jones, Suzanne
    Hainsworth, John
    Infante, Jeff
    Greco, F. Anthony
    Thompson, Dana
    Doss, Habib
    Burris, Howard
    CANCER INVESTIGATION, 2011, 29 (04) : 308 - 312
  • [25] Phase I trial of SNS-595 in patients (pts) with advanced malignancies.
    Advani, R
    Gordon, M
    Hurwitz, H
    Mendelson, D
    Wakelee, H
    Ebbinghaus, S
    Hoch, U
    Silverman, J
    Havrilla, N
    Adelman, D
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9056S - 9056S
  • [26] Phase I trial of SU014813 in patients (pts) with advanced solid malignancies
    Fiedler, W. M.
    Giaccone, G.
    Lasch, P.
    Van der Horst, I.
    Brega, N. M.
    Raber, S.
    Shalinsky, D.
    Ljubmir, V.
    Bokemeyer, C.
    Boven, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [27] Phase I/II trial with 111In-pentetreotide in patients with advanced malignancies.
    Argiris, A
    Peccerillo, K
    Murren, JR
    Cornelius, E
    Modlin, IM
    GASTROENTEROLOGY, 2000, 118 (04) : A515 - A515
  • [28] Bortezomib and pegylated liposomal doxorubicin: phase I trial in patients with advanced hematologic malignancies
    Nature Clinical Practice Oncology, 2005, 2 (6): : 278 - 279
  • [29] A phase I and pharmacologic trial of weekly epothilone B in patients with advanced malignancies.
    Oza, A
    Zamek, RM
    Siu, L
    Locsin, SM
    Moore, M
    Chen, F
    Chen, TL
    Cohen, P
    Rothermel, J
    Rubin, E
    ANNALS OF ONCOLOGY, 2000, 11 : 133 - 133
  • [30] A PHASE-I TRIAL OF CHLORAMBUCIL ADMINISTERED IN SHORT PULSES IN PATIENTS WITH ADVANCED MALIGNANCIES
    BLUMENREICH, MS
    WOODCOCK, TM
    SHERRILL, EJ
    RICHMAN, SP
    GENTILE, PS
    EPREMIAN, BE
    KUBOTA, TT
    ALLEGRA, JC
    CANCER INVESTIGATION, 1988, 6 (04) : 371 - 375
12345